Cargando…

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms

Shengmai injection (SMI), a traditional Chinese herbal medicine extracted from Panax ginseng C.A. Mey., Ophiopogon japonicus (Thunb.) Ker Gawl., and Schisandra chinensis (Turcz.) Baill., has been used to treat acute and chronic heart failure. This study aimed to further clarify the effects of SMI on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yiping, Ruan, Xiaofen, Xu, Xiaowen, Li, Cha, Qiang, Tingting, Zhou, Hua, Gao, Junjie, Wang, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764192/ https://www.ncbi.nlm.nih.gov/pubmed/31616303 http://dx.doi.org/10.3389/fphar.2019.01095

Ejemplares similares

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014)

The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques
por: Ma, Jing, et al.
Publicado: (2023)

LncRNA Chaer Prevents Cardiomyocyte Apoptosis From Acute Myocardial Infarction Through AMPK Activation
por: He, Zhiyu, et al.
Publicado: (2021)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression
por: Cao, Xuefeng, et al.
Publicado: (2021)

A Quantitative Serum Proteomic Analysis Helps to Explore the Comprehensive Mechanism and Identify Serum Biomarkers of Shengmai Injection’s Effect on Isoproterenol-Induced Myocardial Ischemia in Rats
por: Zhang, Xiaoping, et al.
Publicado: (2021)

The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase
por: Jiang, Li-Peng, et al.
Publicado: (2014)

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021)

PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020)

Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches
por: Lu, Juan, et al.
Publicado: (2020)

Suxiao Jiuxin Pill protects cardiomyocytes against mitochondrial injury and alters gene expression during ischemic injury
por: Ruan, Xiaofen, et al.
Publicado: (2017)

STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin
por: Wang, Qiaoyu, et al.
Publicado: (2021)

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II
por: Cheng, Huijun, et al.
Publicado: (2020)

Nelumbo nucifera Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
por: Cho, Soyoung, et al.
Publicado: (2019)

Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
por: Gao, Hui, et al.
Publicado: (2022)

Mitochondrial Fission Is Required for Angiotensin II-Induced Cardiomyocyte Apoptosis Mediated by a Sirt1-p53 Signaling Pathway
por: Qi, Jia, et al.
Publicado: (2018)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

Qiang-Xin 1 Formula Prevents Sepsis-Induced Apoptosis in Murine Cardiomyocytes by Suppressing Endoplasmic Reticulum- and Mitochondria-Associated Pathways
por: Xu, Xiaolong, et al.
Publicado: (2018)

Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy
por: Mondaca-Ruff, David, et al.
Publicado: (2019)

TRPC5-eNOS Axis Negatively Regulates ATP-Induced Cardiomyocyte Hypertrophy
por: Sunggip, Caroline, et al.
Publicado: (2018)

Parkia speciosa Hassk. Empty Pod Extract Alleviates Angiotensin II-Induced Cardiomyocyte Hypertrophy in H9c2 Cells by Modulating the Ang II/ROS/NO Axis and MAPK Pathway
por: Siti, Hawa Nordin, et al.
Publicado: (2021)

Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model
por: Cai, Xin, et al.
Publicado: (2021)

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism
por: Zhang, Xiaoying, et al.
Publicado: (2021)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Zhang, Nan, et al.
Publicado: (2021)

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis
por: Chen, Yu, et al.
Publicado: (2015)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso, Mayarling Francisca, et al.
Publicado: (2021)

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II
por: GUO, HUIXIN, et al.
Publicado: (2015)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

Sevoflurane Postconditioning Attenuates Hypoxia/Reoxygenation Injury of Cardiomyocytes Under High Glucose by Regulating HIF-1α/MIF/AMPK Pathway
por: Ma, Haiping, et al.
Publicado: (2021)

Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
por: Hou, Jing-Yi, et al.
Publicado: (2023)

Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
por: Xiao, Yingying, et al.
Publicado: (2021)

The Natural Flavone Acacetin Confers Cardiomyocyte Protection Against Hypoxia/Reoxygenation Injury via AMPK-Mediated Activation of Nrf2 Signaling Pathway
por: Wu, Wei-Yin, et al.
Publicado: (2018)

An α(2)-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte hypertrophy through mitochondrial-AMPK pathway
por: Weng, Xiaojian, et al.
Publicado: (2020)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023)

The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway
por: Chen, Lina, et al.
Publicado: (2021)

Ciprofol attenuates the isoproterenol-induced oxidative damage, inflammatory response and cardiomyocyte apoptosis
por: Yang, Yunzhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ae3s3m1cdhpccto6enc6m1q6ul